Australia markets closed

Thiogenesis Therapeutics, Corp. (TTI.V)

TSXV - TSXV Real-time price. Currency in CAD
Add to watchlist
0.68000.0000 (0.00%)
At close: 01:08PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
28/02/2022
28/02/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
7,076
6,196
-
-
19.2179
183.51
Total cash
7,076
6,196
-
-
19.2179
183.51
Net receivables
6.003
7.318
-
-
1.3453
2.286
Total current assets
7,243
6,291
3,431
146.431
-
-
Non-current assets
Total non-current assets
0
0
0
0
-
-
Total assets
7,243
6,291
3,431
146.431
-
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
-
-
-
-
320.0001
-
Accounts payable
-
-
-
-
28.8773
11.9001
Accrued liabilities
-
-
245.708
63.08
-
-
Total current liabilities
1,713
307.151
3,492
63.08
-
-
Non-current liabilities
Total non-current liabilities
0
0
0
0
-
-
Total liabilities
1,713
307.151
3,492
63.08
-
-
Stockholders' equity
Common stock
15,010
11,128
302.473
269.928
-
-
Retained earnings
-11,138
-6,177
-453.423
-228.966
-
-
Accumulated other comprehensive income
1,658
1,033
-
-
618.83
606.0518
Total stockholders' equity
5,530
5,983
-61.066
83.351
-
-
Total liabilities and stockholders' equity
7,243
6,291
3,431
146.431
-
-